Sabra Health Care REIT (SBRA) Stock Forecast, Price Target & Predictions
SBRA Stock Forecast
Sabra Health Care REIT stock forecast is as follows: an average price target of $17.29 (represents a -6.99% downside from SBRA’s last price of $18.59) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
SBRA Price Target
The average price target for Sabra Health Care REIT (SBRA) is $17.29 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $13.00. This represents a potential -6.99% downside from SBRA's last price of $18.59.
SBRA Analyst Ratings
According to 9 Wall Street analysts, Sabra Health Care REIT's rating consensus is 'Hold'. The analyst rating breakdown for SBRA stock is 0 'Strong Buy' (0.00%), 4 'Buy' (44.44%), 5 'Hold' (55.56%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Sabra Health Care REIT Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 12, 2024 | Nicholas Joseph | Citigroup | $20.00 | $18.35 | 8.99% | 7.58% |
| Sep 03, 2024 | Michael Lewis | Truist Financial | $18.00 | $17.00 | 5.88% | -3.17% |
| Jun 21, 2024 | David Rodgers | Robert W. Baird | $16.00 | $14.55 | 9.97% | -13.93% |
| May 15, 2024 | Nicholas Yulico | Scotiabank | $15.00 | $14.67 | 2.25% | -19.31% |
| May 31, 2023 | Omotayo Okusanya | Credit Suisse | $13.00 | $10.68 | 21.72% | -30.07% |
| Dec 27, 2021 | Michael R Lewis | Truist Financial | $16.00 | $13.10 | 22.14% | -13.93% |
| Aug 24, 2021 | Jonathan Petersen | Jefferies | $19.00 | $15.35 | 23.78% | 2.21% |
| May 04, 2021 | Daniel Bernstein | Capital One Financial | $20.00 | $16.43 | 21.73% | 7.58% |
The latest Sabra Health Care REIT stock forecast, released on Sep 12, 2024 by Nicholas Joseph from Citigroup, set a price target of $20.00, which represents a 8.99% increase from the stock price at the time of the forecast ($18.35), and a 7.58% increase from SBRA last price ($18.59).
Sabra Health Care REIT Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 3 | 4 |
| Avg Price Target | $19.00 | $18.00 | $17.25 |
| Last Closing Price | $18.59 | $18.59 | $18.59 |
| Upside/Downside | 2.21% | -3.17% | -7.21% |
In the current month, the average price target of Sabra Health Care REIT stock is $19.00, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 2.21% increase as opposed to Sabra Health Care REIT's last price of $18.59. This month's average price target is up 5.56% compared to last quarter, and up 10.14% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 12, 2024 | Citigroup | Neutral | Buy | Upgrade |
| Aug 26, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Aug 23, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| May 21, 2024 | Citigroup | Neutral | Neutral | Hold |
| May 15, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Oct 10, 2023 | Bank of America Securities | Neutral | Buy | Upgrade |
| Sep 20, 2023 | Jefferies | - | Buy | Upgrade |
| Aug 11, 2023 | Bank of America Securities | - | Neutral | Upgrade |
| May 31, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| May 15, 2023 | Credit Suisse | Neutral | Neutral | Hold |
Sabra Health Care REIT's last stock rating was published by Citigroup on Sep 12, 2024. The company Upgrade its SBRA rating from "Neutral" to "Buy".
Sabra Health Care REIT Financial Forecast
Sabra Health Care REIT Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $163.40M | $161.63M | $161.17M | $161.32M | $164.99M | $140.76M | - | $163.10M | $135.66M | $128.59M | $152.93M | $152.37M | $152.05M | $143.25M | $153.92M | $149.35M | $155.76M | $149.83M |
| Avg Forecast | $193.57M | $191.32M | $188.83M | $187.42M | $182.84M | $181.01M | $178.23M | $176.05M | $173.49M | $171.57M | $166.54M | $160.40M | $162.91M | $160.30M | $158.72M | $159.13M | $154.07M | $154.30M | $156.07M | $153.02M | $150.10M | $151.57M | $152.94M | $149.87M | $152.20M | $151.16M | $145.92M | $153.14M | $148.89M | $113.34M |
| High Forecast | $200.77M | $198.44M | $195.86M | $194.40M | $189.65M | $187.75M | $184.87M | $182.60M | $179.94M | $173.60M | $172.74M | $166.37M | $166.04M | $166.27M | $164.63M | $165.05M | $159.80M | $160.04M | $156.07M | $157.99M | $154.97M | $156.49M | $157.90M | $154.73M | $157.14M | $156.07M | $150.66M | $158.11M | $153.72M | $117.02M |
| Low Forecast | $186.60M | $184.44M | $182.03M | $180.68M | $176.26M | $174.50M | $171.82M | $169.71M | $167.24M | $167.74M | $160.54M | $154.63M | $160.82M | $154.53M | $153.01M | $153.40M | $148.52M | $148.74M | $156.07M | $146.19M | $143.40M | $144.80M | $146.11M | $143.17M | $145.40M | $144.41M | $139.40M | $146.30M | $142.24M | $108.28M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.02% | 1.01% | 1.07% | 0.91% | - | 1.07% | 0.90% | 0.85% | 1.00% | 1.02% | 1.00% | 0.95% | 1.05% | 0.98% | 1.05% | 1.32% |
Sabra Health Care REIT's average Quarter revenue forecast for Mar 24 based on 4 analysts is $160.40M, with a low forecast of $154.63M, and a high forecast of $166.37M. SBRA's average Quarter revenue forecast represents a -1.83% decrease compared to the company's last Quarter revenue of $163.40M (Dec 23).
Sabra Health Care REIT EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $59.54M | $103.30M | $101.82M | $102.73M | $21.87M | $86.09M | - | $111.39M | $46.93M | $79.60M | $-63.29M | $102.97M | $105.17M | $105.44M | $99.55M | $106.13M | $111.21M | $94.85M |
| Avg Forecast | $115.45M | $114.11M | $112.62M | $111.78M | $109.05M | $107.96M | $106.30M | $105.00M | $103.47M | $102.33M | $99.33M | $98.10M | $97.17M | $95.61M | $94.67M | $89.18M | $91.89M | $85.20M | $93.08M | $81.07M | $117.67M | $77.45M | $-59.87M | $109.02M | $98.99M | $92.26M | $106.19M | $126.35M | $111.21M | $67.60M |
| High Forecast | $119.74M | $118.36M | $116.81M | $115.95M | $113.11M | $111.98M | $110.26M | $108.91M | $107.32M | $103.54M | $103.02M | $117.72M | $99.03M | $99.17M | $98.19M | $107.02M | $95.31M | $102.24M | $93.08M | $97.29M | $141.20M | $92.94M | $-47.90M | $130.83M | $118.78M | $110.71M | $127.42M | $151.62M | $133.45M | $69.79M |
| Low Forecast | $111.29M | $110.00M | $108.57M | $107.76M | $105.12M | $104.07M | $102.48M | $101.22M | $99.75M | $100.05M | $95.75M | $78.48M | $95.92M | $92.17M | $91.26M | $71.35M | $88.58M | $68.16M | $93.08M | $64.86M | $94.13M | $61.96M | $-71.84M | $87.22M | $79.19M | $73.80M | $84.95M | $101.08M | $88.97M | $64.58M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 1.08% | 1.08% | 1.15% | 0.24% | 1.01% | - | 1.37% | 0.40% | 1.03% | 1.06% | 0.94% | 1.06% | 1.14% | 0.94% | 0.84% | 1.00% | 1.40% |
4 analysts predict SBRA's average Quarter EBITDA for Mar 24 to be $98.10M, with a high of $117.72M and a low of $78.48M. This is 64.77% upper than Sabra Health Care REIT's previous annual EBITDA (Dec 23) of $59.54M.
Sabra Health Care REIT Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $17.16M | $-15.10M | $21.19M | $-9.49M | $-84.95M | $-50.06M | - | $40.60M | $-24.35M | $10.22M | $-132.57M | $33.45M | $37.12M | $36.46M | $29.62M | $35.22M | $39.74M | $23.28M |
| Avg Forecast | $42.28M | $41.85M | $42.72M | $41.75M | $39.34M | $39.52M | $38.29M | $37.82M | $36.64M | $35.78M | $34.81M | $46.24M | $31.44M | $30.39M | $21.82M | $42.04M | $29.92M | $10.94M | $36.87M | $38.21M | $-61.06M | $9.95M | $-125.41M | $35.41M | $34.93M | $31.90M | $31.60M | $41.92M | $39.74M | $30.13M |
| High Forecast | $44.33M | $43.87M | $44.78M | $43.77M | $41.25M | $41.43M | $40.14M | $39.65M | $38.41M | $37.51M | $36.50M | $55.49M | $32.37M | $31.86M | $22.87M | $50.44M | $31.37M | $13.13M | $36.87M | $45.86M | $-48.85M | $11.94M | $-100.33M | $42.50M | $41.92M | $38.28M | $37.92M | $50.31M | $47.69M | $36.16M |
| Low Forecast | $40.30M | $39.89M | $40.72M | $39.79M | $37.50M | $37.67M | $36.50M | $36.05M | $34.92M | $34.79M | $33.18M | $36.99M | $30.52M | $28.97M | $20.80M | $33.63M | $28.52M | $8.75M | $36.87M | $30.57M | $-73.27M | $7.96M | $-150.49M | $28.33M | $27.95M | $25.52M | $25.28M | $33.54M | $31.79M | $24.10M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.55% | -0.50% | 0.97% | -0.23% | -2.84% | -4.58% | - | 1.06% | 0.40% | 1.03% | 1.06% | 0.94% | 1.06% | 1.14% | 0.94% | 0.84% | 1.00% | 0.77% |
Sabra Health Care REIT's average Quarter net income forecast for Mar 24 is $46.24M, with a range of $36.99M to $55.49M. SBRA's average Quarter net income forecast represents a 169.52% increase compared to the company's last Quarter net income of $17.16M (Dec 23).
Sabra Health Care REIT SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $16.68M | $10.76M | $9.53M | $10.50M | $10.85M | $9.68M | - | $10.40M | $8.24M | $8.68M | $8.81M | $8.94M | $8.11M | $7.22M | $8.67M | $8.76M | $5.51M | $8.71M |
| Avg Forecast | $11.51M | $11.38M | $11.23M | $11.15M | $10.87M | $10.76M | $10.60M | $10.47M | $10.32M | $10.20M | $9.90M | $11.84M | $9.69M | $9.53M | $9.44M | $10.76M | $9.16M | $9.29M | $9.28M | $9.78M | $20.65M | $8.45M | $8.33M | $9.46M | $7.63M | $6.31M | $9.25M | $63.80M | $49.32M | $67.11M |
| High Forecast | $11.94M | $11.80M | $11.65M | $11.56M | $11.28M | $11.17M | $10.99M | $10.86M | $10.70M | $10.32M | $10.27M | $14.21M | $9.87M | $9.89M | $9.79M | $12.92M | $9.50M | $11.15M | $9.28M | $11.74M | $24.78M | $10.14M | $10.00M | $11.36M | $9.15M | $7.58M | $11.10M | $76.57M | $59.19M | $80.53M |
| Low Forecast | $11.10M | $10.97M | $10.83M | $10.74M | $10.48M | $10.38M | $10.22M | $10.09M | $9.95M | $9.98M | $9.55M | $9.47M | $9.56M | $9.19M | $9.10M | $8.61M | $8.83M | $7.43M | $9.28M | $7.83M | $16.52M | $6.76M | $6.67M | $7.57M | $6.10M | $5.05M | $7.40M | $51.04M | $39.46M | $53.69M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.72% | 1.13% | 1.01% | 0.98% | 1.18% | 1.04% | - | 1.06% | 0.40% | 1.03% | 1.06% | 0.94% | 1.06% | 1.14% | 0.94% | 0.14% | 0.11% | 0.13% |
Sabra Health Care REIT's average Quarter SG&A projection for Mar 24 is $11.84M, based on 4 Wall Street analysts, with a range of $9.47M to $14.21M. The forecast indicates a -29.02% fall compared to SBRA last annual SG&A of $16.68M (Dec 23).
Sabra Health Care REIT EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.07 | $0.09 | $-0.04 | $-0.37 | $-0.22 | - | $0.18 | $-0.11 | $0.05 | $-0.61 | $0.16 | $0.18 | $0.18 | $0.14 | $0.17 | $0.20 | $0.12 |
| Avg Forecast | $0.18 | $0.18 | $0.18 | $0.18 | $0.17 | $0.17 | $0.16 | $0.16 | $0.16 | $0.15 | $0.15 | $0.14 | $0.13 | $0.13 | $0.09 | $0.12 | $0.13 | $0.16 | $0.16 | $0.15 | $0.13 | $0.14 | $0.15 | $0.17 | $0.18 | $0.18 | $0.15 | $0.20 | $0.20 | $0.17 |
| High Forecast | $0.19 | $0.19 | $0.19 | $0.19 | $0.18 | $0.18 | $0.17 | $0.17 | $0.16 | $0.16 | $0.16 | $0.15 | $0.14 | $0.14 | $0.10 | $0.12 | $0.13 | $0.17 | $0.16 | $0.16 | $0.14 | $0.14 | $0.16 | $0.18 | $0.19 | $0.19 | $0.15 | $0.21 | $0.20 | $0.18 |
| Low Forecast | $0.17 | $0.17 | $0.17 | $0.17 | $0.16 | $0.16 | $0.16 | $0.15 | $0.15 | $0.15 | $0.14 | $0.13 | $0.13 | $0.12 | $0.09 | $0.11 | $0.12 | $0.16 | $0.16 | $0.14 | $0.13 | $0.13 | $0.15 | $0.16 | $0.17 | $0.17 | $0.14 | $0.19 | $0.18 | $0.16 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | -0.50% | 0.96% | -0.36% | -2.89% | -1.35% | - | 1.18% | -0.82% | 0.36% | -3.96% | 0.93% | 0.97% | 1.01% | 0.95% | 0.84% | 1.03% | 0.71% |
According to 4 Wall Street analysts, Sabra Health Care REIT's projected average Quarter EPS for Mar 24 is $0.14, with a low estimate of $0.13 and a high estimate of $0.15. This represents a 138280.00% increase compared to SBRA previous annual EPS of - (Dec 23).
Sabra Health Care REIT Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MPW | Medical Properties Trust | $6.37 | $11.33 | 77.86% | Hold |
| CHCT | Community Healthcare Trust | $17.38 | $30.33 | 74.51% | Buy |
| LTC | LTC Properties | $37.69 | $38.67 | 2.60% | Hold |
| HR | Healthcare Realty Trust | $18.78 | $19.00 | 1.17% | Buy |
| SBRA | Sabra Health Care REIT | $18.59 | $17.29 | -6.99% | Hold |
| CTRE | CareTrust REIT | $31.08 | $25.50 | -17.95% | Buy |
| NHI | National Health Investors | $85.05 | $67.25 | -20.93% | Hold |
| WELL | Welltower | $129.75 | $94.28 | -27.34% | Buy |
SBRA Forecast FAQ
Is Sabra Health Care REIT a good buy?
No, according to 9 Wall Street analysts, Sabra Health Care REIT (SBRA) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 44.44% of SBRA's total ratings.
What is SBRA's price target?
Sabra Health Care REIT (SBRA) average price target is $17.29 with a range of $13 to $20, implying a -6.99% from its last price of $18.59. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Sabra Health Care REIT stock go up soon?
According to Wall Street analysts' prediction for SBRA stock, the company can go down by -6.99% (from the last price of $18.59 to the average price target of $17.29), up by 7.58% based on the highest stock price target, and down by -30.07% based on the lowest stock price target.
Can Sabra Health Care REIT stock reach $30?
SBRA's average twelve months analyst stock price target of $17.29 does not support the claim that Sabra Health Care REIT can reach $30 in the near future.
What is Sabra Health Care REIT's current price target trend?
2 Wall Street analysts forecast a $19 price target for Sabra Health Care REIT (SBRA) this month, up 2.21% from its last price of $18.59. Compared to the last 3 and 12 months, the average price target decreased by -3.17% and decreased by -7.21%, respectively.
What are Sabra Health Care REIT's analysts' financial forecasts?
Sabra Health Care REIT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $718.14M (high $744.86M, low $692.28M), average EBITDA is $428.32M (high $444.26M, low $412.9M), average net income is $154.98M (high $162.48M, low $147.73M), average SG&A $42.71M (high $44.3M, low $41.17M), and average EPS is $0.663 (high $0.695, low $0.632). SBRA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $761.14M (high $789.47M, low $733.73M), average EBITDA is $453.97M (high $470.86M, low $437.62M), average net income is $168.59M (high $176.75M, low $160.7M), average SG&A $45.26M (high $46.95M, low $43.63M), and average EPS is $0.721 (high $0.756, low $0.687).
Did the SBRA's actual financial results beat the analysts' financial forecasts?
Based on Sabra Health Care REIT's last annual report (Dec 2023), the company's revenue was $647.51M, beating the average analysts forecast of $641.06M by 1.01%. Apple's EBITDA was $194.84M, missing the average prediction of $376.62M by -48.27%. The company's net income was $13.76M, missing the average estimation of $125.68M by -89.06%. Apple's SG&A was $47.47M, beating the average forecast of $39.42M by 20.42%. Lastly, the company's EPS was $0.0001, missing the average prediction of $0.473 by -99.98%. In terms of the last quarterly report (Dec 2023), Sabra Health Care REIT's revenue was $163.4M, beating the average analysts' forecast of $162.91M by 0.30%. The company's EBITDA was $59.54M, missing the average prediction of $97.17M by -38.72%. Sabra Health Care REIT's net income was $17.16M, missing the average estimation of $31.44M by -45.44%. The company's SG&A was $16.68M, beating the average forecast of $9.69M by 72.16%. Lastly, the company's EPS was $0.0001, missing the average prediction of $0.135 by -99.93%